News | Artificial Intelligence | March 28, 2024

Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical Trials

CREDENCE and PACIFIC-1 study data demonstrate potential power of AI-QCT ISCHEMIA

CREDENCE and PACIFIC-1 study data demonstrate potential power of AI-QCT ISCHEMIA

March 28, 2024 —  Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, shared findings from a study published online in the Journal of the American College of Cardiology: Cardiovascular Imaging on March 13, 2024. The study describes the validation of Cleerly's artificial intelligence-guided quantitative coronary CT angiography (AI-QCT) ISCHEMIA technology for diagnostic accuracy and prognostic risk stratification.

In two trials,1-2 the CREDENCE and PACIFIC-1 studies comprised a total of 513 patients who underwent coronary CT angiography, myocardial perfusion imaging with single photon emission CT (SPECT), and fractional flow reserve derived from CT (FFRCT). For patients with an abnormal Cleerly AI-QCT ISCHEMIA finding, a positive result was associated with an approximately 7-fold increase of adverse cardiovascular events during an 8-year follow-up. Collectively, this study shows that Cleerly AI-QCT ISCHEMIA, when used in conjunction with Cleerly LABS, can provide a 3-in-1 approach for the assessment of atherosclerosis, stenosis and ischemia.

"This pivotal study was performed in two different international populations which shows that CCTA analyzed with the Cleerly AI-QCT ISCHEMIA device provides an accurate assessment of coronary ischemia,” said James P. Earls, MD, Chief Medical Officer of Cleerly. “These promising findings offer the possibility of a novel care paradigm for symptomatic coronary artery disease evaluation that performs comprehensive analysis of atherosclerosis, stenosis and ischemia from a single non-invasive CCTA test, which may offer the benefit of guiding clinical decision making for both coronary revascularization and medical therapy."

These study results come after Cleerly announced that its Cleerly ISCHEMIA software device is billable using the new Category I CPT code 75580.

For more information: www.cleerlyhealth.com

Find more ACC24 conference coverage here

References:

  1. Nurmohamed NS, Danad I, Jukema RA, et al. High Diagnostic Accuracy of AI-ISCHEMIA in Comparison to PET, FFR-CT, SPECT, and Invasive FFR: A Pacific Substudy. J Am Coll Cardiol. 2023 Mar, 81 (8_Supplement) 1362.
  2. Nurmohamed NS, Danad I, Jukema RA, et al. Development and Validation of a Quantitative Coronary CT Angiography Model for Diagnosis of Vessel-Specific Coronary Ischemia. JACC Cardiovasc Imaging. 2024 Feb 29:S1936-878X(24)00039-1. doi: 10.1016/j.jcmg.2024.01.007. Epub ahead of print. PMID: 38483420.
  3. Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Nov 30;144(22):e368-e454.

Related Content

News | Artificial Intelligence

May 15, 2025 – Royal Philips, a global leader in health technology, has released its 10th annual Future Health Index ...

Home May 19, 2025
Home
News | Artificial Intelligence

April 22, 2025 — Mount Sinai researchers studying hypertrophic cardiomyopathy (HCM) have calibrated an artificial ...

Home April 22, 2025
Home
News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Home April 16, 2025
Home
News | Artificial Intelligence

April 4, 2025 — Viz.ai has been named an Award Winner in the 2025 Edison Awards, for the third year in a row. Viz HCM ...

Home April 07, 2025
Home
News | Artificial Intelligence

March 3, 2025 — Microsoft Corp. has unveiled Microsoft Dragon Copilot, an AI assistant for clinical workflow that brings ...

Home March 03, 2025
Home
News | Artificial Intelligence

Feb. 25, 2025 — Heartflow, Inc., a provider of AI technology for coronary artery disease (CAD) management, recently ...

Home February 26, 2025
Home
News | Artificial Intelligence

Feb. 6, 2025 — Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung ...

Home February 10, 2025
Home
News | Artificial Intelligence

Feb. 4, 2025 — Riverain Technologies recently announced it expanded across eight countries in 2024 and added nearly 50 ...

Home February 04, 2025
Home
News | Artificial Intelligence

Jan. 22, 2025 — Public Responsibility in Medicine and Research (PRIM&R) recently called for establishing clear ethical ...

Home January 23, 2025
Home
News | Artificial Intelligence

Jan. 22, 2025 -- HeartFlow, Inc., a provider of non-invasive artificial intelligence (AI) heart care solutions, and ...

Home January 23, 2025
Home
Subscribe Now